Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis
Public ClinicalTrials.gov record NCT04250207. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12 Week, Phase 2 Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Patients With Fuchs Endothelial Corneal Dystrophy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to investigate the effect of K-321 in patients with Fuchs endothelial corneal dystrophy (FECD) after descemetorhexis.
Study identification
- NCT ID
- NCT04250207
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 23, 2020 (Actual)
- Primary completion
- Sep 22, 2021 (Actual)
- Completion
- Jun 27, 2022 (Actual)
- Last update posted
- Nov 5, 2024
2020 – 2022
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jules Stein Eye Institute | Los Angeles | California | 90095 | — |
| Byers Eye Institute at Stanford | Palo Alto | California | 94304 | — |
| UC Davis Eye Center | Sacramento | California | 95817 | — |
| Sacramento Eye Consultants | Sacramento | California | 98515 | — |
| Gorovoy MD Eye Specialists | Fort Myers | Florida | 33907 | — |
| UF Health Eye Center | Gainesville | Florida | 32605 | — |
| Chicago Cornea Consultants Ltd | Hoffman Estates | Illinois | 60169 | — |
| Arbor Centers For Eyecare | Orland Park | Illinois | 60467 | — |
| Price Vision Group | Indianapolis | Indiana | 46260 | — |
| Massachusetts Eye and Ear Infirmary | Boston | Massachusetts | 02114 | — |
| W Kellogg Eye Center | Ann Arbor | Michigan | 48105 | — |
| Minnesota Eye Consultants | Bloomington | Minnesota | 55431 | — |
| Eye Associates of New Mexico | Albuquerque | New Mexico | 87109 | — |
| NY Langone Health | New York | New York | 10017 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | — |
| Devers Eye Institute | Portland | Oregon | 97210 | — |
| Casey Eye Institute - OHSU | Portland | Oregon | 97239 | — |
| Vantage EyeCare, LLC | Bala-Cynwyd | Pennsylvania | 19004 | — |
| UPMC Eye Center | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04250207, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04250207 live on ClinicalTrials.gov.